Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hite Christopher
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.54%)
Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-General Atlantic, L.P.(5.6%),GAP Coinvestments CDA, L.P.(5.6%), etc.
Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(9.2%),Morgan Stanley Investment Management Inc.(8.9%)
Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.099%),Abigail P. Johnson(7.099%)
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Avara Management Ltd
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Avara Management Ltd
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Avara Management Ltd
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Avara Management Ltd
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Legorreta Pablo G.
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lloyd George W.
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A
Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L
No Data